Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids.

Englezou PC, Sapet C, Démoulins T, Milona P, Ebensen T, Schulze K, Guzman CA, Poulhes F, Zelphati O, Ruggli N, McCullough KC.

Mol Ther Nucleic Acids. 2018 Sep 7;12:118-134. doi: 10.1016/j.omtn.2018.04.019. Epub 2018 May 4.

2.

Glycan recognition by human blood mononuclear cells with an emphasis on dendritic cells.

Rapoport EM, Khaidukov SV, Gaponov AM, Pazynina GV, Tsygankova SV, Ryzhov IM, Belyanchikov IM, Milona P, Bovin NV, McCullough KC.

Glycoconj J. 2018 Apr;35(2):191-203. doi: 10.1007/s10719-017-9811-6. Epub 2018 Jan 31.

PMID:
29388006
3.

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice.

Ebensen T, Debarry J, Pedersen GK, Blazejewska P, Weissmann S, Schulze K, McCullough KC, Cox RJ, Guzmán CA.

Front Immunol. 2017 Sep 28;8:1223. doi: 10.3389/fimmu.2017.01223. eCollection 2017.

4.

Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure.

Démoulins T, Ebensen T, Schulze K, Englezou PC, Pelliccia M, Guzmán CA, Ruggli N, McCullough KC.

J Control Release. 2017 Nov 28;266:256-271. doi: 10.1016/j.jconrel.2017.09.018. Epub 2017 Sep 19.

PMID:
28935594
5.

Dendritic Cell Sensing of Hydrophobic Di- and Triacylated Lipopeptides Self-Assembled within Synthetic Virus-like Particles.

Sharma R, Ghasparian A, Robinson JA, McCullough KC.

J Immunol. 2017 Jul 15;199(2):734-749. doi: 10.4049/jimmunol.1600521. Epub 2017 Jun 19.

6.

Self-Replicating RNA Vaccine Delivery to Dendritic Cells.

Démoulins T, Englezou PC, Milona P, Ruggli N, Tirelli N, Pichon C, Sapet C, Ebensen T, Guzmán CA, McCullough KC.

Methods Mol Biol. 2017;1499:37-75. Review.

PMID:
27987142
7.

Sensing of Porcine Reproductive and Respiratory Syndrome Virus-Infected Macrophages by Plasmacytoid Dendritic Cells.

García-Nicolás O, Auray G, Sautter CA, Rappe JC, McCullough KC, Ruggli N, Summerfield A.

Front Microbiol. 2016 Jun 2;7:771. doi: 10.3389/fmicb.2016.00771. eCollection 2016.

8.

Virus replicon particles expressing porcine reproductive and respiratory syndrome virus proteins elicit immune priming but do not confer protection from viremia in pigs.

Eck M, Durán MG, Ricklin ME, Locher S, Sarraseca J, Rodríguez MJ, McCullough KC, Summerfield A, Zimmer G, Ruggli N.

Vet Res. 2016 Feb 19;47:33. doi: 10.1186/s13567-016-0318-0.

9.

Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines.

Démoulins T, Milona P, Englezou PC, Ebensen T, Schulze K, Suter R, Pichon C, Midoux P, Guzmán CA, Ruggli N, McCullough KC.

Nanomedicine. 2016 Apr;12(3):711-722. doi: 10.1016/j.nano.2015.11.001. Epub 2015 Dec 1.

PMID:
26592962
10.

Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo.

McCullough KC, Bassi I, Milona P, Suter R, Thomann-Harwood L, Englezou P, Démoulins T, Ruggli N.

Mol Ther Nucleic Acids. 2014 Jul 8;3:e173. doi: 10.1038/mtna.2014.24.

11.

Alginate-coated chitosan nanogels differentially modulate class-A and class-B CpG-ODN targeting of dendritic cells and intracellular delivery.

Démoulins T, Milona P, McCullough KC.

Nanomedicine. 2014 Nov;10(8):1739-49. doi: 10.1016/j.nano.2014.06.003. Epub 2014 Jun 15.

PMID:
24941461
12.

Self-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic Nanoparticles.

McCullough KC, Milona P, Thomann-Harwood L, Démoulins T, Englezou P, Suter R, Ruggli N.

Vaccines (Basel). 2014 Oct 16;2(4):735-54. doi: 10.3390/vaccines2040735. Review.

13.

Porcine circovirus type 2 stimulates plasmacytoid dendritic cells in the presence of IFN-gamma.

Baumann A, McCullough KC, Summerfield A.

Vet Immunol Immunopathol. 2013 Dec 15;156(3-4):223-8. doi: 10.1016/j.vetimm.2013.10.005. Epub 2013 Oct 16.

PMID:
24183591
14.

Lipid nanoparticle-based delivery of RNA.

McCullough KC.

Nanomedicine (Lond). 2013 Jun;8(6):872-3. No abstract available.

PMID:
23878858
15.

Targeting poly-d,l-lactide-co-glycolide-based vaccines to skin dendritic cells.

McCullough KC.

Nanomedicine (Lond). 2013 Jun;8(6):872. No abstract available.

PMID:
23878855
16.

Glycopeptide targeting of vaccine antigens to dendritic cells.

McCullough KC.

Nanomedicine (Lond). 2013 Jun;8(6):871-2. No abstract available.

PMID:
23878853
17.

Targeting specific receptors on dendritic cells.

McCullough KC.

Nanomedicine (Lond). 2013 Jun;8(6):871. doi: 10.2217/nnm.13.79. No abstract available.

18.

Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells.

Démoulins T, Bassi I, Thomann-Harwood L, Jandus C, Kaeuper P, Simon HU, von Gunten S, McCullough KC.

Nanomedicine. 2013 Aug;9(6):806-17. doi: 10.1016/j.nano.2013.01.002. Epub 2013 Jan 22.

PMID:
23347894
19.

Functional RNA delivery targeted to dendritic cells by synthetic nanoparticles.

McCullough KC, Bassi I, Démoulins T, Thomann-Harwood LJ, Ruggli N.

Ther Deliv. 2012 Sep;3(9):1077-99. Review.

PMID:
23035593
20.

Synthetic virus-like particles target dendritic cell lipid rafts for rapid endocytosis primarily but not exclusively by macropinocytosis.

Sharma R, Ghasparian A, Robinson JA, McCullough KC.

PLoS One. 2012;7(8):e43248. doi: 10.1371/journal.pone.0043248. Epub 2012 Aug 14.

Supplemental Content

Loading ...
Support Center